In fact, in our work, most endothelial biomarkers, but not P-BNP, seem to differentiate AHF phenotype of presentation, since admission concentrations of S-ICAM-1, S-VCAM-1 and S-Endocan were significantly higher in CS patients. This evidence concerns the gene VCAM1 and Cowden syndrome 1.